Nice app
Nice information!!!
SITC Immunotherapy Guidelines
Разработчик:
SOCIETY FOR IMMUNOTHERAPY OF CANCER
Описание
The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guidelines (CPG) Mobile App is the first and only tool of its kind, offering direct, easy, portable access to SITC’s CPGs via phone or tablet. Highlighting key information from SITC’s published guidelines, the SITC CPG App features evidence- and expert consensus based-recommendations on all aspects of immunotherapy treatment as well as interactive tools and companion educational resources. From biomarkers and therapy selection to quality of life and management of immune-related adverse events, busy clinicians will find the SITC CPG App as the go-to resource on when and how to use immunotherapy to help improve outcomes for patients with cancer.
Key App Features
*Clean and simple navigation with a modern interface
*Interactive tools and tables at your fingertips
*Advanced search functionality for fast access to the content clinicians need
*Bookmarking and annotation capabilities throughout for future fast-reference
*Timely updates when new practice-changing data or approvals become available
*Companion educational offerings to enhance understanding of guideline recommendations
*Free download with open-access content
About SITC’s Guidelines
SITC’s Clinical Practice Guidelines (CPGs) offer a vital resource for the practicing oncology community by providing practical, actionable recommendations to help cancer care providers develop immunotherapy treatment plans for their patients. The CPGs are developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve outcomes for patients with cancer. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure a fair, transparent and balanced process for creating the CPGs. Each CPG expert panel is comprised of a comprehensive mix of academic physicians and researchers, nurses, patients, and patient advocates invited from institutions across the United States. The guidelines are reviewed on an ongoing basis to account for newly available clinical trial data and FDA approvals.
About SITC
SITC is a 501(c)(3) not-for-profit medical professional society of influential research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders dedicated to improving cancer patient outcomes by advancing both the science behind – and the clinical application of – cancer immunotherapy. SITC aims to one day make the word “cure” a reality for cancer patients everywhere. www.sitcancer.org
sitcancer.org/CPG-app
On social - #SITCGuidelines
Скрыть
Показать больше...
Key App Features
*Clean and simple navigation with a modern interface
*Interactive tools and tables at your fingertips
*Advanced search functionality for fast access to the content clinicians need
*Bookmarking and annotation capabilities throughout for future fast-reference
*Timely updates when new practice-changing data or approvals become available
*Companion educational offerings to enhance understanding of guideline recommendations
*Free download with open-access content
About SITC’s Guidelines
SITC’s Clinical Practice Guidelines (CPGs) offer a vital resource for the practicing oncology community by providing practical, actionable recommendations to help cancer care providers develop immunotherapy treatment plans for their patients. The CPGs are developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve outcomes for patients with cancer. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure a fair, transparent and balanced process for creating the CPGs. Each CPG expert panel is comprised of a comprehensive mix of academic physicians and researchers, nurses, patients, and patient advocates invited from institutions across the United States. The guidelines are reviewed on an ongoing basis to account for newly available clinical trial data and FDA approvals.
About SITC
SITC is a 501(c)(3) not-for-profit medical professional society of influential research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders dedicated to improving cancer patient outcomes by advancing both the science behind – and the clinical application of – cancer immunotherapy. SITC aims to one day make the word “cure” a reality for cancer patients everywhere. www.sitcancer.org
sitcancer.org/CPG-app
On social - #SITCGuidelines
Скриншоты
SITC Immunotherapy Guidelines Частые Вопросы
-
Приложение SITC Immunotherapy Guidelines бесплатное?
Да, SITC Immunotherapy Guidelines полностью бесплатное и не содержит встроенных покупок или подписок.
-
Является ли SITC Immunotherapy Guidelines фейковым или мошенническим?
Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.
Спасибо за ваш голос -
Сколько стоит SITC Immunotherapy Guidelines?
Приложение SITC Immunotherapy Guidelines бесплатное.
-
Сколько зарабатывает SITC Immunotherapy Guidelines?
Чтобы получить оценку дохода приложения SITC Immunotherapy Guidelines и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.
Оценки пользователей
5 из 5
1 оценок в Швейцария
5 star
1
4 star
0
3 star
0
2 star
0
1 star
0
История оценок
SITC Immunotherapy Guidelines Отзывы Пользователей
Оценки
История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Приложение еще не было в топах
SITC Immunotherapy Guidelines Конкуренты
| Name | Скачивания (30d) | Ежемесячный доход | Отзывы | Оценки | Последнее обновление | |
|---|---|---|---|---|---|---|
HemeOncBuddy
hemeonc trials
|
Открыть
|
Открыть
|
0
|
|
1 год назад | |
ASTCT Practice Guidelines
|
Открыть
|
Открыть
|
0
|
|
4 месяца назад | |
Research To Practice
|
Открыть
|
Открыть
|
0
|
|
5 месяцев назад | |
ESMO Interactive Guidelines
|
Открыть
|
Открыть
|
0
|
|
1 год назад | |
Manual of Clinical Oncology
with Expert Recommentations
|
Открыть
|
Открыть
|
0
|
|
3 месяца назад | |
Immuno-Oncology
from @ Point of Care™
|
Открыть
|
Открыть
|
0
|
|
4 месяца назад | |
Physicians Cancer Chemotherapy
Clinical Therapy Drug Guide
|
Открыть
|
Открыть
|
0
|
|
7 месяцев назад | |
ASCO Guidelines
|
Открыть
|
Открыть
|
0
|
|
1 год назад | |
CARTOX
Toxicity assessment tool
|
Открыть
|
Открыть
|
0
|
|
2 года назад | |
ASH Pocket Guides
|
Открыть
|
Открыть
|
0
|
|
9 месяцев назад |
SITC Immunotherapy Guidelines Установки
30дн.
SITC Immunotherapy Guidelines Доход
30дн.SITC Immunotherapy Guidelines Доходы и Загрузки
Получите ценные инсайты о производительности SITC Immunotherapy Guidelines с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.
Информация о приложении
- Категория
- Medical
- Разработчик
- SOCIETY FOR IMMUNOTHERAPY OF CANCER
- Языки
- English, German
- Последнее обновление
- 1.7 (9 месяцев назад )
- Выпущено
- Aug 30, 2021 (3 года назад )
- Также доступно в
- Соединенные Штаты , Индия , Германия , Великобритания , Италия , Португалия , Китай , Австралия , Норвегия , Румыния , Россия , Вьетнам , Индонезия , Польша , Греция , Франция , Финляндия , Саудовская Аравия , Республика Корея , Дания , Турция , Тайвань , Швейцария , Канада , Бельгия , Перу , Новая Зеландия , Нигерия , Нидерланды , Южно-Африканская Республика , Филиппины , Пакистан , Швеция , Сингапур , Таиланд , Украина , ОАЭ , Египет , Австрия , Азербайджан , Бразилия , Беларусь , Чили , Колумбия , Чехия , Доминиканская Республика , Алжир , Эквадор , Малайзия , Испания , Гонконг (САР) , Венгрия , Ирландия , Израиль , Япония , Кувейт , Казахстан , Ливан , Мексика
- Обновлено
- 2 дня назад
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.
AppTail.